Hepatitis B is the most widespread serious liver infection globally, caused by the hepatitis B virus (HBV), which targets and ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early diagnosis and treatment. Advances in antiviral ...

During a live event, Chandler H. Park, MD, and participants discuss NCCN guidelines and TiNivo-2 data for second-line renal ...

This space already includes two approved CAR T-cell therapies: Johnson & Johnson/Legend’s Carvykti and Bristol Myers Squibb’s ...

The B.C. Supreme Court has certified a Canada-wide class-action lawsuit against consultancy firm McKinsey & Company as part ...

Lymphoma research presented at ASCO 2025 highlighted investigational treatments for FL, HL, and DLBCL as well as a revised staging system for NKTCL.

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed multiple myeloma, according to researchers.

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Severe autoimmune-mediated neuropathies, such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

PRESS RLEASE – Attorney General Dave Yost has announced that the attorneys general of 49 states, the District of Columbia and ...